Inventaire - 友達とコミュニティはあなたのベストな図書館です - Inventaire

Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers

著者

Toyomasa Katagiri

この作品が含まれる作品: International Journal of Clinical Oncology

出版日: 2013-07-03

言語: 英語

Cites articles 16

Date

タイトル

著者

2012-04-17

Body mass index and survival after breast cancer diagnosis in Japanese women
2012-08-27

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer

Vered Stearns, エディス・A・ペレス, George Sledge, Jennifer Ligibel
2012-11-23

Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women
2012-10-01

Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer

Ana Maria Gonzalez-Angulo
2010-06-14

Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial

Ivana Sestak, Anthony Howell, Mitch Dowsett, Jack Cuzick
2010-11-29

Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study

Rachel Ballard-Barbash, Leslie Bernstein, Kathy B Baumgartner, Melinda L Irwin, Anne McTiernan, Richard Baumgartner, Ashley Wilder Smith, Jean De Dieu Tapsoba
2009-05-12

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

Charles M. Perou, Maggie Chon U Cheang, Sherri R Davies
2008-02-01

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

Matthias Egger, Andrew G. Renehan, Richard F Heller
2008-07-29

Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women

Janet Daling, Kathleen E. Malone, Peggy L. Porter, アマンダ・フィップス・グリーン
2008-04-25

High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome

Kathleen I. Pritchard, Pamela J Goodwin
2008-03-01

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group

Eugenio Maiorano, Mauro Giuseppe Mastropasqua, Aron Goldhirsch, Meredith M Regan, Piergiovanni Grigolato
2004-06-01

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
2003-08-01

Central obesity and breast cancer risk: a systematic review

Lee Hooper, Anthony Howell
2003-05-01

Adiposity and sex hormones in postmenopausal breast cancer survivors

Rachel Ballard-Barbash, Leslie Bernstein, Shelley S. Tworoger, Frank Z. Stanczyk, Melinda L Irwin, Anne McTiernan, Richard Baumgartner, Frank D Gilliland, Kumar B. Rajan, Yutaka Yasui
2002-01-01

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

Pamela J Goodwin
2001-08-01

Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma

Janet Daling, Kathleen E. Malone, Peggy L. Porter

記事 - wd:Q43948558

Welcome to Inventaire

友達やコミュニティの図書館

もっと調べる

you are offline